Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on June 22, 2026

Jun. 22, 2026

Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026

Indeterminate GlobeNewswire

Jun. 22, 2026

FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire

Jun. 22, 2026

Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds

Indeterminate GlobeNewswire

Jun. 22, 2026

Edible Garden's Pickle Party™ Named "Overall Plant-Based Snack Product of the Year" in 2026 Mindful Awards Program

Indeterminate GlobeNewswire

Jun. 22, 2026

European Equity Research Partners starts coverage of Virtualware

Indeterminate GlobeNewswire

Jun. 22, 2026

Lithium Argentina Reports 2026 Annual General Meeting Results

Indeterminate GlobeNewswire

Jun. 22, 2026

GXO to Support Action’s Expansion Across Central and Southern Italy with New Distribution Center in Ferentino

Indeterminate GlobeNewswire

Jun. 22, 2026

NobelClad Expands Capabilities in the Americas with Weld Overlay Services

Indeterminate GlobeNewswire

Jun. 22, 2026

G2 Goldfields Receives Court Approval for Arrangement With G Mining and Spin-Out of G3 Goldfields

Indeterminate GlobeNewswire

Jun. 22, 2026

CureWise Founder and CEO Steve Brown to Speak at Aspen Ideas: Health 2026 and Launch AI-Powered Precision Oncology Platform

Indeterminate GlobeNewswire

Jun. 22, 2026

Sparklight Strengthens Local Communities through More than $125,000 in Charitable Giving Fund Grants

Indeterminate GlobeNewswire

Jun. 22, 2026

TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation

Indeterminate GlobeNewswire

Jun. 22, 2026

Atlas Energy Corp. Announces Appointments to Subsidiary Board and Extension of TSXV Sandbox Exit Deadline

Indeterminate GlobeNewswire

Jun. 22, 2026

Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)

Indeterminate GlobeNewswire

Jun. 22, 2026

NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression

Indeterminate GlobeNewswire

Jun. 22, 2026

WTOP News Names HRCI A Winner Of The Greater Washington Area Top Workplaces 2026 Award

Indeterminate GlobeNewswire

Jun. 22, 2026

Coppernico Metals Announces Upsized LIFE Offering

Indeterminate GlobeNewswire

Jun. 22, 2026

Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

Indeterminate GlobeNewswire

Jun. 22, 2026

MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder

Indeterminate GlobeNewswire

Jun. 22, 2026

Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus

Indeterminate GlobeNewswire